Rybak SM - Search Results

1

RNA damage and inhibition of neoplastic endothelial cell growth: effects of human and amphibian ribonucleases.

Newton DL, Kaur G, Rhim JS, Sausville EA, Rybak SM. Newton DL, et al. Among authors: rybak sm. Radiat Res. 2001 Jan;155(1 Pt 2):171-174. doi: 10.1667/0033-7587(2001)155[0171:rdaion]2.0.co;2. Radiat Res. 2001. PMID: 11121230

2

"Vasocrine" formation of tumor cell-lined vascular spaces: implications for rational design of antiangiogenic therapies.

Rybak SM, Sanovich E, Hollingshead MG, Borgel SD, Newton DL, Melillo G, Kong D, Kaur G, Sausville EA. Rybak SM, et al. Cancer Res. 2003 Jun 1;63(11):2812-9. Cancer Res. 2003. PMID: 12782586

3

Unique recombinant human ribonuclease and inhibition of Kaposi's sarcoma cell growth.

Newton DL, Rybak SM. Newton DL, et al. Among authors: rybak sm. J Natl Cancer Inst. 1998 Dec 2;90(23):1787-91. doi: 10.1093/jnci/90.23.1787. J Natl Cancer Inst. 1998. PMID: 9839518

4

Cell cycle-related differences in susceptibility of NIH/3T3 cells to ribonucleases.

Smith MR, Newton DL, Mikulski SM, Rybak SM. Smith MR, et al. Among authors: rybak sm. Exp Cell Res. 1999 Feb 25;247(1):220-32. doi: 10.1006/excr.1998.4317. Exp Cell Res. 1999. PMID: 10047464

5

Preparation of recombinant RNase single-chain antibody fusion proteins.

Newton DL, Rybak SM. Newton DL, et al. Among authors: rybak sm. Mol Biotechnol. 2002 Jan;20(1):63-76. doi: 10.1385/MB:20:1:063. Mol Biotechnol. 2002. PMID: 11876300 Review.

6

Crystallographic and functional studies of a modified form of eosinophil-derived neurotoxin (EDN) with novel biological activities.

Chang C, Newton DL, Rybak SM, Wlodawer A. Chang C, et al. Among authors: rybak sm. J Mol Biol. 2002 Mar 15;317(1):119-30. doi: 10.1006/jmbi.2002.5406. J Mol Biol. 2002. PMID: 11916383

7

Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents: a new generation of therapeutics.

Hursey M, Newton DL, Hansen HJ, Ruby D, Goldenberg DM, Rybak SM. Hursey M, et al. Among authors: rybak sm. Leuk Lymphoma. 2002 May;43(5):953-9. doi: 10.1080/10428190290021380. Leuk Lymphoma. 2002. PMID: 12148905 Review.

8

Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains.

Newton DL, Xue Y, Olson KA, Fett JW, Rybak SM. Newton DL, et al. Among authors: rybak sm. Biochemistry. 1996 Jan 16;35(2):545-53. doi: 10.1021/bi951650w. Biochemistry. 1996. PMID: 8555226

9

Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.

Rybak SM, Pearson JW, Fogler WE, Volker K, Spence SE, Newton DL, Mikulski SM, Ardelt W, Riggs CW, Kung HF, Longo DL. Rybak SM, et al. J Natl Cancer Inst. 1996 Jun 5;88(11):747-53. doi: 10.1093/jnci/88.11.747. J Natl Cancer Inst. 1996. PMID: 8637029

10

Expression and characterization of a cytotoxic human-frog chimeric ribonuclease: potential for cancer therapy.

Newton DL, Xue Y, Boqué L, Wlodawer A, Kung HF, Rybak SM. Newton DL, et al. Among authors: rybak sm. Protein Eng. 1997 Apr;10(4):463-70. doi: 10.1093/protein/10.4.463. Protein Eng. 1997. PMID: 9194172

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters